Flatiron is revolutionizing cancer care by combining technology with vast oncological data to enhance treatment, research, and clinical trials. They provide clinicians, researchers, and regulators with the tools to learn quickly and improve care. With over 3.5 million de-identified patient records, Flatiron supports real-world evidence generation, helping to develop treatment strategies and regulatory submissions. Their platforms, such as Clinical Pipe and Flatiron Assist, streamline clinical workflows, facilitate evidence-based treatment decisions, and accelerate clinical research. They work towards closing the gap between care and research, ensuring efficient trials and aiding drug development with comprehensive insights from real-world data.

Flatiron

Flatiron improves cancer care through technology, research, and real-world evidence.

Flatiron taps $130M Series B round

Recent Funding News